» Articles » PMID: 31192857

Paradoxical Pustular Psoriasis in a Patient With Psoriatic Arthritis on Secukinumab Treatment

Overview
Date 2019 Jun 14
PMID 31192857
Citations 5
Authors
Affiliations
Soon will be listed here.
Citing Articles

A case of secukinumab-induced psoriasis in a 25-year-old man with improved hidradenitis suppurativa.

Yousefian F, Griffith V, Stallings A, Rupley K JAAD Case Rep. 2025; 53():90-92.

PMID: 39823051 PMC: 11736156. DOI: 10.1016/j.jdcr.2024.08.027.


Paradoxical psoriasis induced by IL-17 inhibitors: a case series of patients with axial spondyloarthritis and a systematic literature review.

Chaitidis N, Papadopoulou Z, Varvara S, Panagiotidis M, Katsigianni I, Sakellariou G Rheumatol Int. 2024; 44(11):2659-2668.

PMID: 38914777 DOI: 10.1007/s00296-024-05647-9.


Paradoxical reaction to IL-17A inhibitor: a case report and literature review.

Ren J, Deng L, Guo S, Liu H Front Med (Lausanne). 2024; 11:1364127.

PMID: 38695018 PMC: 11061499. DOI: 10.3389/fmed.2024.1364127.


Successful guselkumab treatment of a refractory psoriasis patient with Graves' disease: a case report.

Shao X, Huang K, Chen A, Liu C, Xiong J, Pan Y J Int Med Res. 2024; 52(4):3000605241239856.

PMID: 38656269 PMC: 11044775. DOI: 10.1177/03000605241239856.


Paradoxical Psoriasis and Worsening Spondylitis Due to Secukinumab in a Patient With Ankylosing Spondylitis: A Case Report and Literature Review.

Alnaqbi K, Al Zeyoudi J, Fazal F, Alhaj O, Jassim I, Albreiki F Cureus. 2023; 15(12):e50726.

PMID: 38111814 PMC: 10726796. DOI: 10.7759/cureus.50726.